Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:
- Lower risks of very preterm birth and low birth weight
- Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
- Persistent increased risk of gestational diabetes
Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.
Read the full text to learn more.”
Proceed to the video attached to the post.
Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn
Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 16, 2026, 19:56Dina Ibrahem: Poor ICM vs. Poor TE
-
Oct 16, 2026, 19:47Sean Lauber: NIPT and Amniocentesis after PGT-A Reveal Few Abnormalities
-
Oct 16, 2026, 19:42Devyanshi Dixit: C-Section vs. Vaginal Birth – 2 Birth Paths, 2 Very Different Recoveries
-
Oct 16, 2026, 19:32Pawel Kordowitzki: Maternal Vitamin D Homeostasis, Pregnancy Outcomes and Offspring Health
-
Oct 16, 2026, 19:13Shizuko Takahashi: Our Study on Women’s Experiences of Assisted Reproductive Care in China Has Been Accepted by RBMO
-
Oct 16, 2026, 19:09ESHRE Announces ECRES-GESEA Reproductive Surgery Training and Certification in Slovenia
-
Oct 16, 2026, 18:20Kabita KB: What Happens if PLCZ1 Is Defective?
-
Oct 16, 2026, 18:12Partha Sarathi Das: From Reproductive Lifespan to Reproductive Healthspan
-
Oct 16, 2026, 18:05Joyce Harper: It Was a Pleasure to Give 2 Talks Celebrating World Menopause Day